Enbrel (etanercept) is a medication used to treat several inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It works by blocking a protein called tumor necrosis factor-alpha (TNF-alpha), which is involved in the body's inflammatory response.
By blocking this protein, Enbrel can help reduce inflammation and relieve symptoms associated with these conditions including joint pain, swelling, and skin plaques. Enbrel is administered through subcutaneous injection, which can be self-administered by patients or given by a healthcare provider. The dosing frequency and amount will depend on the specific condition being treated and the patient's response to the medication.
However, as a healthcare provider, obtaining access to Enbrel enrollment forms can be time-consuming and confusing. In this article, we will provide you with access to Enbrel enrollment forms and introduce you to the Enbrel SupportPlus™ Program – which provides a variety of HCP and patient resources to streamline the process of prescribing Enbrel to treat patients.